Drug
Bhb 1893
Bhb 1893: highest development phase Phase 3, developed by Braveheart Bio, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Braveheart Bio, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| BHB-1893 NCT07755904 | Phase 3 | Cardiomyopathy, Hypertrophic Obstructive |
Latest
Follow Bhb 1893 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.